GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer
NCT00320411
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms, Breast
Interventions
DRUG:
lapatinib
Sponsor
GlaxoSmithKline